Please use this identifier to cite or link to this item:
https://doi.org/10.1089/dia.2011.0232
Title: | Fulminant type 1 diabetes mellitus: A study of nine cases | Authors: | Su, X.-F. Fu, L.-Y. Wu, J.-D. Xu, X.-H. Li, H.-Q. Sun, R. Ye, L. Lee, K.-O. Ma, J.-H. |
Issue Date: | 1-Apr-2012 | Citation: | Su, X.-F., Fu, L.-Y., Wu, J.-D., Xu, X.-H., Li, H.-Q., Sun, R., Ye, L., Lee, K.-O., Ma, J.-H. (2012-04-01). Fulminant type 1 diabetes mellitus: A study of nine cases. Diabetes Technology and Therapeutics 14 (4) : 325-329. ScholarBank@NUS Repository. https://doi.org/10.1089/dia.2011.0232 | Abstract: | Objective: The study aims to explore the prevalence and clinical features of fulminant type 1 diabetes mellitus (F1DM). Subjects and Methods: We analyzed 11,202 patients who were diagnosed having diabetes and admitted to the Department of Endocrinology, Nanjin First Hospital, Nanjin, China, from September 2005 to April 2011. Among 198 patients classified having type 1 diabetes mellitus (T1DM), nine patients were diagnosed having F1DM. Clinical features of F1DM were analyzed and compared with typical T1DM. Results: The prevalence of F1DM was 4.5% (nine of 198 T1DM patients) in this study. F1DM patients had significantly high levels of random blood glucose (40±9mmol/L). However, glycated hemoglobin (7.1±1.0%) and C-reactive peptide (0.21±0.15μg/L) at 2h postprandial were significantly lower in F1DM patients compared with typical T1DM patients. Six of them had flu-like symptoms. Five of them showed gastrointestinal symptoms. Three patients experienced disturbance of consciousness. However, none of these symptoms was found in patients with typical T1DM. A continuous intravenous insulin infusion therapy using a portable pump was given during the acute phase to control hyperglycemia and ketoacidosis. All F1DM patients survived after treatment. Conclusion: In this single hospital-based study, nine Chinese patients met the criteria for diagnosis of F1DM. Although F1DM may be fatal, prompt treatment is required and useful to rescue these patients. © Copyright 2012, Mary Ann Liebert, Inc. 2012. | Source Title: | Diabetes Technology and Therapeutics | URI: | http://scholarbank.nus.edu.sg/handle/10635/126813 | ISSN: | 15209156 | DOI: | 10.1089/dia.2011.0232 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.